# Trial of Orencia in Patients With Myasthenia Gravis

> **NCT03059888** · EARLY_PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 6 (actual)

## Conditions studied

- Myasthenia Gravis

## Interventions

- **DRUG:** Abatacept Injection

## Key facts

- **NCT ID:** NCT03059888
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-12
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Mutual decision of sponsor and investigator due to logistical challenges
- **Last updated:** 2019-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059888, "Trial of Orencia in Patients With Myasthenia Gravis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03059888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*